Has Blessie Valdez received payments from drug or device companies?

Yes. Drug and device makers reported $4,083 in general payments to Blessie Valdez across 237 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Blessie Valdez did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Blessie Valdez come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Blessie Valdez

Psychiatry · Sugar Land, TXNPI 1154982486

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.2% of the total across 237 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,521 and has fallen 94.1% since, to $90 in 2025.

$4,083in general payments, 2019–2025

Across 237 payments — averaging $17.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$733
Takeda Pharmaceuticals U.S.A., Inc.$387
Johnson & Johnson$367
Otsuka America Pharmaceutical, Inc.$358
Sunovion Pharmaceuticals Inc.$296
AbbVie$233
plus $2K from 19 others

What the payments were for

Food & beverage$4,00898%
Education$752%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	52	$733
Takeda Pharmaceuticals U.S.A., Inc.	20	$387
Johnson & Johnson	19	$367
Otsuka America Pharmaceutical, Inc.	16	$358
Sunovion Pharmaceuticals Inc.	28	$296
AbbVie	13	$233
Indivior Inc.	11	$229
Vanda Pharmaceuticals Inc.	13	$228
Alkermes, Inc.	8	$150
Corium, LLC	9	$149
Axsome Therapeutics, Inc.	5	$132
Teva Pharmaceuticals USA, Inc.	7	$128
Neurocrine Biosciences, Inc.	5	$105
Eisai Inc.	4	$99
Neos Therapeutics, LP	6	$98
Lundbeck LLC	4	$83
Ironshore Pharmaceuticals Inc.	5	$78
Noven Therapeutics, LLC	3	$66
Jazz Pharmaceuticals Inc.	2	$37
Almatica Pharma LLC	2	$32
E.r. Squibb & Sons, L.L.C.	1	$25
Tris Pharma Inc	1	$21
Sun Pharmaceutical Industries Inc.	1	$19
Noven Pharmaceuticals, Inc.	1	$17
Idorsia Pharmaceuticals US Inc	1	$15

How this compares

$4,083 in reported general payments places this provider in the 85th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Venlafaxine Hcl ErVenlafaxine Hcl	13	$72

Paid to pharmacies, not to this prescriber.

Other psychiatry in Sugar Land

Deena GandhiSugar Land$125K
Rakesh JainLake Jackson$7.2M
Arvinder Pal WaliaAustin$2.5M
Suresh SureddiPlano$2.2M
Martin GuerreroEl Paso$2M
Marty BennettAddison$1.8M
Matthew BramsHouston$1.5M
Vikram MehraKaty$1.2M
Joel HolinerDallas$948K
Frank ChenHouston$941K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →